Status:
RECRUITING
Intestinal Metaplasia Cohort for Gastric Cancer Prediction
Lead Sponsor:
Seoul National University Hospital
Conditions:
Intestinal Metaplasia of Gastric Mucosa
Eligibility:
All Genders
18+ years
Brief Summary
In this study, we aim to establish a prospective cohort of patients with endoscopically and histologically confirmed intestinal metaplasia, collect gastric mucosal tissue samples from this cohort, and...
Detailed Description
Patients visiting Seoul National University Hospital, who have previously received an incidental diagnosis of intestinal metaplasia during a prior gastroscopy examination, will be considered as potent...
Eligibility Criteria
Inclusion
- Patients who visit Seoul National University Hospital
- Patients who have been visually diagnosed with intestinal metaplasia at a prior exam
Exclusion
- Patients who have been previously diagnosed with gastric cancer or adenoma
- Patients who have previously received gastrectomy
Key Trial Info
Start Date :
September 13 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2033
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT06075199
Start Date
September 13 2023
End Date
June 30 2033
Last Update
November 29 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Hospital
Seoul, South Korea